Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Alarcon

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Urology|November 20, 2015
Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor CellsEric C Kauffman, Min-Jung Lee, Sylvia V Alarcon, et al.
Current Molecular Medicine|July 19, 2012
Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapyS V Alarcon, M Mollapour, M-J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomasArun Rajan, Ronan J Kelly, Jane B Trepel, et al.
IJTLD Open|March 18, 2026
Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TBE Herrera-Flores, E Shen, D Vargas-Vasquez, et al.
The Lancet. Oncology|July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trialAndrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Urology|November 20, 2015
Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor CellsEric C Kauffman, Min-Jung Lee, Sylvia V Alarcon, et al.
Current Molecular Medicine|July 19, 2012
Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapyS V Alarcon, M Mollapour, M-J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomasArun Rajan, Ronan J Kelly, Jane B Trepel, et al.
IJTLD Open|March 18, 2026
Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TBE Herrera-Flores, E Shen, D Vargas-Vasquez, et al.
The Lancet. Oncology|July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trialAndrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
Pageof 3